KHTRF / Knight Therapeutics Inc. - Depositi SEC, Relazione annuale, dichiarazione di delega

Knight Therapeutics Inc.
US ˙ OTCPK ˙ CA4990531069

Statistiche di base
LEI 549300LNW93V3HRS7610
CIK 1632373
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Knight Therapeutics Inc.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
May 7, 2024 SC 13G/A

SXTP / 60 Degrees Pharmaceuticals, Inc. / Knight Therapeutics (Barbados) Inc. - SC 13G/A Passive Investment

SC 13G/A 1 ef20028560sc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* (Name of Issuer) 60 Degrees Pharmaceuticals, Inc. Common Stock, par va

December 18, 2023 SC 13G

SXTP / 60 Degrees Pharmaceuticals, Inc. / Knight Therapeutics (Barbados) Inc. - SC 13G Passive Investment

SC 13G 1 ef20016456sc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. -)* 60 Degrees Pharmaceuticals, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 83006G104 (CUSIP Number) July 11, 2023 (Date of Event Which Requires Filing of this Statement) Check the appr

August 16, 2017 SC 13D/A

SNYR / Synergy CHC Corp. / Knight Therapeutics (Barbados) Inc. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* SYNERGY CHC CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 87165D 109 (CUSIP Number) Michel Loustric The Business Center, Upton, St Michael BB11103 Barbados (246) 622-1975 (Name, Address and Telephone Number of Person Authorized to Re

May 23, 2017 SC 13D/A

SNYR / Synergy CHC Corp. / Knight Therapeutics (Barbados) Inc. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* SYNERGY CHC CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 87165D 109 (CUSIP Number) Michel Loustric The Business Center, Upton, St Michael BB11103 Barbados (246) 622-1975 (Name, Address and Telephone Number of Person Authorized to Re

December 23, 2016 SC 13D/A

SNYR / Synergy CHC Corp. / Knight Therapeutics (Barbados) Inc. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* SYNERGY CHC CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 87165D 109 (CUSIP Number) Michel Loustric The Business Center, Upton, St Michael BB11103 Barbados (246) 266-8631 (Name, Address and Telephone Number of Person Authorized to Re

December 23, 2016 EX-99.1

EX-99.1

Exhibit 99.1

December 23, 2016 EX-99.2

EX-99.2

Exhibit 99.2

December 17, 2015 SC 13D/A

SNYR / Synergy CHC Corp. / Knight Therapeutics (Barbados) Inc. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* SYNERGY CHC CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 87165D 109 (CUSIP Number) Michel Loustric The Business Center, Upton, St Michael BB11103 Barbados (246) 266-8631 (Name, Address and Telephone Number of Person Authorized to Re

November 23, 2015 SC 13D

SNYR / Synergy CHC Corp. / Knight Therapeutics (Barbados) Inc. - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* SYNERGY CHC CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 87165D 109 (CUSIP Number) Michel Loustric The Business Center, Upton, St Michael BB11103 Barbados (246) 266-8631 (Name, Address and Telephone Number of Person Authorized to Rec

February 2, 2015 SC 13G

SNYR / Synergy CHC Corp. / Knight Therapeutics (Barbados) Inc. - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* SYNERGY STRIPS CORP. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 87165D 109 (CUSIP Number) Jack Ross 3435 Ocean Park #107-447, Santa Monica, CA 90405 (615) 939-9004 (Name, Address and Telephone Number of Person Authorized to Receive Notic

Other Listings
CA:GUD 6,44 CA$
DE:04K 3,98 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista